Location: Home
  • search
  • go
  • Relate News
  • 9/24/2021Snapshot of BMI System Financial Performance in H1/2021
  • 9/24/2021Recent Executive Moves
  • 9/23/2021Sihuan/Xuanzhu and SignalChem Announce Licensing Deal for SLC-391 in G...
  • 9/23/2021Guangzhou Pharma Eyes Public Listing of Subsidiaries
  • 9/23/2021Cytiva Triples Bioprocessing Single-Use Consumables Capacity in China
  • 9/23/2021Scopus Granted Chinese Patent for CpG-STAT3 Inhibitor DUET-02
  • 9/23/2021Innovent's sNDA for Sintilimab in Combo with Chemotherapy as First-L...
  • 9/23/2021Prevalence of Depressive Disorders and Treatment in China: A Cross-Sec...
  • 9/22/2021NMPA Issues Q2/2021 Drug Regulatory Statistics Report
  • 9/22/2021China-based CMS Joins BaseLaunch as Latest Partner
  • 9/20/2021Leading Chinese Pharma Players Move on the Korean Market
  • 9/20/2021CDE Solicits Public Comments on Draft of the Technical Guidelines for ...
  • 9/20/2021CNIPA Issues Interpretation of Administrative Adjudication of Patent L...
  • 9/19/2021WiCON Publishes the China Pharmaceutical Guide 2021 (16th Edition)
  • 9/17/2021Tarveda and SciClone Expand Partnership with a License Deal for HSP9...
  • 9/17/2021CDE Solicits Public Comments on the Draft Guidelines for Centralized M...
  • 9/17/2021Celsion and Hainan Poly Pharm Sign Agreement to Manufacture Celsion's ...
  • 9/17/2021Henlius's NDA for Novel Anti-PD-1 mAb Serplulimab as First-Line Treatm...
  • 9/17/2021CDE Issues Technical Guidance for Bioequivalence Study of 16 Drugs
  • 9/17/2021Recent Executive Moves
  • 9/16/2021Luye Pharma Ties Up with ESTEVE for Its Alzheimer's Patch in Spain
  • 9/16/2021Everest Medicines, Sinovent and SinoMab Enter Licensing Deal for Novel...
  • 9/16/2021AstraZeneca, Daiichi Sankyo Begin New Gastric Cancer Enhertu Trial in ...
  • 9/16/2021Asymchem and LaNova Medicines Form Partnership, Expanding Biological C...
  • 9/16/2021Chinese Pursuit of Avigan Patent Faces Pushback in Japan
  • 9/16/2021 Zai Lab Expands U.S. Operations with Key Presence in Cambridge Biotec...
  • 9/16/2021Innovent Releases Phase 2 Results of Pemigatinib in Chinese Patients w...
  • 9/16/2021CDE Seeks Comments on Draft Chinese Translation of ICH Guideline E14
  • 9/16/2021CDE Publicizes the List of Reference Formulations for GQCE Studies (49...
  • 9/16/2021Takeaways from Recent Implementation of China's Patent Linkage System
  • Page:113/719 Total number of articles:21546: [First][<<] [111] [112] [113] [114] [115] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group